Product Name |
Recombinant Human Left-right Determination Factor 2 (LEFTY2) Protein |
Product Overview |
This recombinant human Left-right Determination Factor 2 (LEFTY2) protein includes amino acids 78-366aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id |
O00292 |
Recommended Name |
Left-right determination factor 2 |
Gene Name |
LEFTY2 |
Synonyms |
Left-right determination factor 2; Endometrial bleeding-associated factor; Left-right determination |
Species |
Human |
Predicted Molecular Mass |
39.1 kDa |
Expression System |
Mammalian Cell |
Expression Range |
78-366aa |
Tag |
N-6His |
Purity |
>90% |
Formulation |
Lyophilized |
Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
Research Area |
Cancer |
Target Function |
Required for left-right (L-R) asymmetry determination of organ systems in mammals. May play a role in endometrial bleeding. |
Subcellular Location |
Secreted. |
Protein Family |
TGF-beta family |
Associated Diseases |
Left-right axis malformations (LRAM) |
Tissue Specificity |
Mesenchymal cells of the endometrial stroma. |